In early 2020, the COVID-19 pandemic caused big disruptions worldwide.
Hospitals and medical offices in the United States suddenly ran low on important items like personal protective equipment (PPE), ventilators, medicines, and vaccines.
These shortages happened even though there was careful planning and spending on supply chains before the pandemic.
One major problem was that supply chains depended too much on a few suppliers, often all in one area.
When factories or ports closed in one part of the world, it stopped the entire delivery chain.
According to the Access to Medicine Foundation, relying on only one or a few suppliers created a big risk that could cause shortages and hurt patients.
Also, sudden jumps in demand were too much for supply chains that focused on being efficient and predictable rather than flexible.
The “just in time” model keeps very low inventory to save on storage costs.
This meant hospitals had little extra supply when problems happened.
Shipping delays, fewer workers in factories and logistics, and government rules made these problems worse.
The pandemic showed that healthcare supply chains must be changed to handle shocks and keep important products available even when conditions change.
Healthcare managers and supply chain leaders are now encouraged to shift from the old “just in time” system to a “just in case” system.
This new way means keeping more supplies on hand, working with different suppliers, and improving demand predictions to avoid shortages.
“Just in case” means having extra stocks of important medicines and supplies ready so care continues even if usual deliveries are late or stopped.
This system values being ready over saving money because running out of supplies can have serious effects on health and costs.
The Access to Medicine Foundation discussed three strategies to make healthcare supply chains stronger worldwide, which apply to the U.S. as well:
For U.S. hospitals and clinics, this means not only relying on a few vendors from home or abroad but also thinking about local makers or other suppliers.
They should also keep larger supplies of critical items like vaccines, important medicines, and medical tools.
Technology is very important for improving healthcare supply chains.
During the pandemic, many companies and health groups started using digital tools faster to handle disruptions and meet changing needs.
A survey by McKinsey showed the pandemic sped up online and digital supply chain work by about three years worldwide, with some regions moving even faster.
In healthcare, new tools like artificial intelligence (AI), robots, real-time data tracking, and cloud platforms are changing how supply chains are planned and run.
These tools make it easier for decision-makers to watch stock levels, demand, and shipping details at any time.
Research by Ernst & Young found that 92% of companies kept investing in supply chain technology during the pandemic.
Many U.S. healthcare groups worked harder to add automation and AI tools to better predict demand and improve buying decisions.
Digital tools help healthcare systems get ready for different situations, like sudden vaccine demand or shipping delays.
For example, AI can look at lots of data including patient patterns, outbreaks, and supplier info to guess what supplies will be needed and when.
Blockchain technology is another improvement.
Though still new, blockchain offers a secure, shared record that increases trust among all players in a supply chain.
In healthcare, blockchain can track every shipment of medicine or vaccine to make sure it is real and in good condition during delivery.
Deloitte showed how blockchain helps in clinical trials by managing patient permission and tracking samples more accurately.
It also helps reduce paperwork and rules costs in medicine shipments.
Blockchain needs agreement from many groups and better tech to grow well but can improve trust and tracking.
For U.S. medical office leaders, blockchain could lower risks of fake products entering supply chains, improve product recalls, and make following rules easier.
Building a strong healthcare supply chain is not only about technology—it also needs training workers.
Surveys from Ernst & Young show 61% of companies planned to teach new skills to supply chain staff by 2022 to use digital tools better.
For healthcare providers, this means teaching staff about digital buying platforms, data analytics, and AI tools.
IT managers and supply chain leaders must get comfortable using new technologies that are now part of daily work.
Getting clinical and admin teams to work closely together helps match supply with actual patient needs and spot shortages faster.
Artificial intelligence and workflow automation are important for making healthcare supply chains faster and more flexible.
These tools handle repetitive tasks like answering supply questions, scheduling orders, and managing stock with little human help.
AI systems watch stock levels in real time and trigger reorders automatically when supplies get too low.
This lowers mistakes and stops running out of stock.
AI also studies past usage and outside data like disease outbreaks or seasonal changes to suggest the right inventory amounts.
For healthcare office managers, AI-based phone systems and answering services like Simbo AI improve communication with suppliers and teams.
These systems answer questions about order statuses and deliveries automatically so staff can focus more on complex work and patient care.
Workflow automation links buying processes with budgeting and finance, helping track costs and resources better.
AI can find buying trends, helping make better contracts or find new suppliers more quickly.
With more digital tools, AI makes supply chains clearer, more flexible, and less likely to have delays.
Moving from “just in time” to “just in case” shows a larger change toward stronger, tech-based healthcare operations.
The pandemic showed how costly it is to be unprepared and how important readiness is for unexpected events.
Investments in technology like AI, automation, and blockchain will keep shaping supply chains to make them clearer, faster, and more flexible.
Training workers and improving teamwork between providers and suppliers will help U.S. medical offices give steady patient care without breaks.
Strong leaders who focus on supply chain safety, plus spending on new technology and varied buying strategies, can help healthcare providers in the U.S. build better supply systems for the future.
By using these steps, medical managers, practice owners, and IT staff can make healthcare supply chains safer, work better, and respond well to future problems, keeping care steady for all patients.
The pandemic highlighted vulnerabilities such as shortages, stockouts, sudden demand spikes, and disruptions to shipping. An over-reliance on a small number of suppliers, often concentrated in one region, was identified as a significant risk.
A transition from a ‘just in time’ to a ‘just in case’ model is crucial to ensure continuous delivery of critical medicines and vaccines, especially in response to potential disruptions.
1. Prioritize global health security in decision-making. 2. Widen and strengthen the supplier base. 3. Identify and fix the weakest links in access to medicine.
Changes in procurement policies should focus on ensuring continuity of supply by diversifying the supplier base and considering a wider range of suppliers in tender processes.
Technology can enhance smart forecasting, demand planning, and facilitate better communication between suppliers and procurers, improving the resilience of supply chains.
A diverse supplier base reduces dependency on single sources, mitigating risks of shortages. This expands access to essential medicines and ensures greater supply chain robustness.
Collaboration between multinational corporations and local manufacturers, along with technology transfers and capacity building, can enhance local production and availability of essential medicines.
The industry faced interconnections issues, sudden disruptions, and specific regional vulnerabilities that affected access to medicines, vaccines, and healthcare products.
The goal is to stimulate good practices and address vulnerabilities in the global supply of essential medicines and vaccines, by bringing various essential healthcare stakeholders together.
The Foundation plans to engage with companies, governments, and procurers to adopt best practices, and will expand its focus to key sectors like generic medicines, vaccines, and diagnostics.